(Q43848098)

27 November 2017

title

CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR. (English)

1 reference

27 November 2017

Schulenburg A

1

1 reference

27 November 2017

Watkins-Riedel T

2

1 reference

27 November 2017

Greinix HT

3

1 reference

27 November 2017

Rabitsch W

4

1 reference

27 November 2017

Loidolt H

5

1 reference

27 November 2017

Keil F

6

1 reference

27 November 2017

Mitterbauer M

7

1 reference

27 November 2017

Kalhs P

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Bone Marrow Transplantation

27 November 2017

published in

1 reference

27 November 2017

volume

28

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

765-768

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703227

27 November 2017

exact match

0 references

cites work

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

Risk factors for cytomegalovirus infection after human marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

7 January 2021

Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

7 January 2021

Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

7 January 2021

HLA-Restricted Cytotoxic T Lymphocytes Are an Early Immune Response and Important Defense Mechanism in Cytomegalovirus Infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703227

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703227

1 reference

Dimensions Publication ID

27 November 2017

1022088077

0 references

1 reference